Anzeige
Mehr »
Login
Samstag, 02.03.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
High-Grade News! Heute wieder ein 57% Kursspektakel?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBoston Scientific claims first US approval for drug-coated coronary balloon
FrPhilips, Siemens, GE HealthCare roll out new hardware at European radiology meeting
FrProtein parser Alamar Biosciences collects $128M to fund analyzer launch
FrKaruna 'vigorously' denies wrongdoing in shareholder lawsuit over BMS deal disclosures
FrSQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell
FrFogPharma clears $145M series E thanks to Alexis Borisy, ex-J&J CEO Alex Gorsky
FrAfter pair of failures, PTC finds a path through FDA jungle for Friedreich ataxia med
FrAfter COVID decline, Pfizer builds out cancer pipeline and leans into ADCs
DoHeadlands acquires Pharmasite to expand mental health and CNS trials
DoGritstone lays off 40% of team after delayed launch of COVID vax trial
DoMedtronic asks ITC to wade into Axonics patent spat, filing request for exclusion order
DoJ&J secures European afib approval for Varipulse pulsed field ablation system
DoFDA flagged animal testing issues at Neuralink lab last year: Reuters
DoCytoDyn finally clears FDA hold on HIV program after two years
DoAfter saving Yumanity's assets, Kineta faces shutdown as private placement fails to show up
DoWith seeds from Turning Point, a new biotech blooms with $100M to take on small molecules
DoIronwood seeing STARS as $1B bet hits in phase 3-and triggers 30% stock drop
DoNovo Nordisk's new Boston-area campus reflects 'competitive' R&D growth, and not just for GLP-1s
MiMedidata extends contract with Thermo Fisher PPD, with AI solution a key focus
MiMainstay Medical merits $125M for back pain-focused neuromod implant
MiNo ongoing sale process at Cytokinetics, CEO says following Novartis acquisition rumors
MiFDA issues alert over implant risks of Hologic's breast tissue marker
MiWith cash runways ending this year, Nicox and Longeveron trim staff and narrow focus
MiPalatin CEO claims 'a positive study on its face,' despite dry eye drug's primary endpoint miss
MiGinkgo-a-go-go! Bioworks company forges 3 acquisition deals